News

Eylea (aflibercept) is a biologic drug prescribed to help prevent vision loss in certain situations. It’s a liquid solution given by healthcare professionals as an injection into the eye.
Eylea is a liquid that is injected directly into the eye by a health care professional. This type of shot is called an intravitreal injection. When you first start using Eylea, you will receive a ...
88% of EYLEA HD patients had a last assigned dosing interval of ≥12 weeks at week 156, while sustaining visual and anatomic improvements achieved ...
An EMA committee has issued a positive opinion for a label extension that would allow six-month injection intervals for Eylea ...
EYLEA ® (aflibercept) Injection 2 mg is a prescription medicine ... Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer ...
EYLEA ® (aflibercept) Injection 2 mg is a prescription medicine ... Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer ...
plus a reduced need for injections into the eye with current therapy Eylea. On the strength of the results, 4DMT is planning to start a phase 3 trial of the gene therapy by the end of the first ...
EYLEA® (aflibercept) Injection 2 mg is a prescription medicine ... Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer ...
EYLEA ® (aflibercept) Injection 2 mg is a prescription medicine approved for ... Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, ...